WWW.WSJ.COM
Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
0 Commentarii 0 Distribuiri 107 Views